Evidence map›Paper›PMID 22614753›Full record

ReviewNature reviews. Gastroenterology & hepatology2012

What is personalized medicine and what should it replace?

David C Whitcomb

Abstract readReview
In one paragraph

Review in Nature reviews. Gastroenterology & hepatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Personalized medicine approaches in cystic fibrosis related pancreatitis.American journal of translational research · 2022
    Article
  8. Review
  9. Review
  10. Article
  11. Precision medicine for pancreatic diseases.Current opinion in gastroenterology · 2020
    Review
  12. Review
  13. Anesthesiomics: Could a New Name Be Coined for Anesthesia?Anesthesiology and pain medicine · 2020
    Article
  14. Article
  15. Primer on Precision Medicine for Complex Chronic Disorders.Clinical and translational gastroenterology · 2019
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Precision Medicine: Where have we reached and where are we headed?Sultan Qaboos University medical journal · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

David C WhitcombDivision of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh, Medical Arts Building, 3708 Fifth Avenue, Suite 401.5, Pittsburgh, PA 15213, USA. whitcomb@pitt.edu

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
North American Pancreatitis Study 2 (NAPS2)R01DK061451 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WHITCOMB, DAVID CLEMENT · 2002 to 2010
$4.9M
NAPS2-AS: Race Dependent Risk for PancreatitisR01DK077906 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YADAV, DHIRAJ · 2010 to 2013
$2.3M
MOLECULAR GENETICS OF HEREDITARY PANCREATITISR01DK054709 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WHITCOMB, DAVID CLEMENT · 1999 to 2008
$2.0M
NAPS2 Continuation Genome Wide Association Study of PancreatitisR56DK061451 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WHITCOMB, DAVID CLEMENT · 2011 to 2011
$1.3M
NCI NIH HHS P30 CA047904NCI NIH HHS P30CA047904NCRR NIH HHS UL1 RR024153NIDDK NIH HHS DK054709NIDDK NIH HHS DK061451NIDDK NIH HHS DK077906NIDDK NIH HHS R01 DK054709NIDDK NIH HHS R01 DK061451NIDDK NIH HHS R01 DK077906NIDDK NIH HHS R56 DK061451
6 · The paper itself

Abstract

Personalized medicine is a new framework for medical care that involves modelling and simulation of a disease on the basis of its underlying mechanisms. This strategy must replace the 20(th) century paradigm of defining disease by pathology or associated signs and symptoms and conducting outcomes research that is based on the presence or absence of the disease syndrome. New technologies, including next-generation sequencing, the 'omics' and powerful computers provide massive amounts of accurate data. However, attempts to understand complex disorders by applying these new technologies within the 20(th) century framework have failed to produce the expected medical advances. To help physicians embrace a paradigm shift, the limitations of the old framework and major advantages of the new framework must be demonstrated. Chronic pancreatitis is an ideal complex disorder to study to consider the pros and cons of the two frameworks, because the pancreas is such a simple organ for disease modelling, and the advantages of personalized medicine are so profound.

Indexed as

Pancreatitis, ChronicAcute DiseaseComputer SimulationGenomicsHumansModels, BiologicalPharmacogeneticsPrecision Medicine

Identifiers

PMID22614753
PMCPMC3684057

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.